Osprey Private Wealth LLC Purchases 1,240 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Osprey Private Wealth LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 21.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,915 shares of the healthcare conglomerate's stock after acquiring an additional 1,240 shares during the quarter. UnitedHealth Group makes up 2.1% of Osprey Private Wealth LLC's portfolio, making the stock its 20th biggest position. Osprey Private Wealth LLC's holdings in UnitedHealth Group were worth $3,622,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $6,375,744,000. GAMMA Investing LLC raised its holdings in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $1,914,740,000. Amundi raised its holdings in shares of UnitedHealth Group by 97.2% during the fourth quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock worth $3,183,132,000 after purchasing an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. HSBC reaffirmed a "reduce" rating and issued a $270.00 price objective (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $426.52.

UnitedHealth Group Trading Down 1.6%

Shares of UNH traded down $5.11 during midday trading on Friday, hitting $313.39. The stock had a trading volume of 13,729,200 shares, compared to its average volume of 7,185,784. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The business has a 50-day simple moving average of $391.47 and a two-hundred day simple moving average of $476.22. The firm has a market cap of $284.28 billion, a P/E ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the previous year, the business earned $6.91 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be issued a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.82%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. The trade was a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Kristen Gil acquired 3,700 shares of the business's stock in a transaction that occurred on Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now owns 3,818 shares of the company's stock, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by company insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.